By Chris Rowe on Friday, July 28, 2017
Today I'm going to give you something that (I hope) will stay with you for the rest of your days (and may there be many, many more of them!) I have pages and pages of trading tips that I’ve jotted down…
By Costas Bocelli on Thursday, July 27, 2017
Amazon.com (AMZN) has taken another merciless stride towards world domination. Last month, the internet retail giant agreed to buy the upscale grocery chain Whole Foods Market (WFM) for $13.4 billion. News of the deal that Amazon was getting into the grocery…
By Chris Rowe on Wednesday, July 26, 2017
As for me, I stopped trying to call the direction of the market a long time ago. And I'm not going to try call market direction ever again. That said, I do know that when the market looks the way it looks right…
By Costas Bocelli on Wednesday, July 19, 2017
Billionaire hedge fund manager David Einhorn is having a horrendous year. Einhorn’s Greenlight Capital reported that the fund is down 2.8 percent through June, according to his recent investment letter. Even worse, the S&P 500 index has gained 8.3 percent…
By Chris Rowe on Tuesday, July 18, 2017
Have you been invested in large-cap technology stocks or financial stocks? If so, then you've been crushing it. If not, then you've probably been a little up or a little down, even though market averages have been breaking highs. When…
By Costas Bocelli on Thursday, July 13, 2017
The methods used to analyze securities and make investment decisions typically fall into two broad categories. In the investment world, fundamental and technical analysis fall on completely opposite sides of the spectrum. Fundamental analysis is a method of evaluating securities by…
By Chris Rowe on Wednesday, July 12, 2017
Let's cut to the chase. IBB is a buy. This is for educational purposes only and yadda yadda. Consult your investment pro before doing anything. The iShares NASDAQ Biotechnology Index ETF (SYMBOL: IBB) spent the last 18 months building a…
By Costas Bocelli on Friday, July 7, 2017
About a month ago we told you to pay close attention to the results of the annual stress tests among the big U.S. banks. The main point of the article was to alert investors that despite the pullback from the…
By Chris Rowe on Thursday, July 6, 2017
Hey folks! Chris Rowe here. I'll be filling in for my friend Costas Bocelli today. Something rare is occurring -- and it's teeing up a perfect opportunity for individual investors. Pay close attention to this one because it can really bolster profits...…